# Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER)

> **NCT02013700** · PHASE1 · TERMINATED · sponsor: **Joshua M Hare** · enrollment: 9 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis (IPF)

## Interventions

- **BIOLOGICAL:** Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs)
- **BIOLOGICAL:** matched placebo

## Key facts

- **NCT ID:** NCT02013700
- **Lead sponsor:** Joshua M Hare
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-11-13
- **Primary completion:** 2015-12-11
- **Final completion:** 2016-11-24
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Study completed
- **Last updated:** 2021-03-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02013700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02013700, "Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02013700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*